Lexapro
Online, Description,
Chemistry, Ingredients -
Lexapro Pharmacology,
Pharmacokinetics, Studies,
Metabolism - Lexapro
Indications, Dosage, Storage,
Stability - Lexapro Side
Effects, and Drug Interactions
- Lexapro Warnings,
Precautions, Pregnancy,
Nursing, Abuse - Lexapro
Overdose, Contraindications
and Information - Lexapro
Patient, Information,
Instructions
Lexapro
(escitalopram
oxalate)
TABLETS/ORAL SOLUTION
Suicidality in Children and
Adolescents Lexapro
Antidepressants
Lexapro increased the
risk of suicidal Lexapro thinking and
behavior (suicidality) Lexapro in
short-term studies in children
and adolescents with Major
Depressive Lexapro Disorder (MDD) and
other psychiatric Lexapro disorders.
Anyone Lexapro considering the use of
Lexapro or any other Lexapro
antidepressant in a child or
adolescent must Lexapro balance this
risk with Lexapro the clinical need.
Patients who are started on
therapy should Lexapro be observed
closely for Lexapro clinical worsening,
suicidality, Lexapro or unusual changes
in behavior. Families and
caregivers Lexapro should be Lexapro advised
of Lexapro the need for close Lexapro
observation Lexapro and communication
with the prescriber. Lexapro is
not approved Lexapro for use in
pediatric patients. (See
WARNINGS and PRECAUTIONS:
Pediatric Use)
Pooled analyses Lexapro of short-term
(4 to 16 weeks) placebo-
controlled Lexapro trials of 9
antidepressant Lexapro drugs (SSRIs
and others) in children and
adolescents Lexapro with major
depressive disorder (MDD),
obsessive compulsive disorder
(OCD), or Lexapro other psychiatric
disorders (a total of 24
trials Lexapro involving over Lexapro 4400
patients) have revealed a
greater Lexapro risk of adverse events
representing suicidal thinking
or behavior (suicidality)
during the Lexapro first few months of
treatment in those receiving
antidepressants. The average
risk of such events in patients
receiving antidepressants was
4%, twice Lexapro the placebo risk of
2%. No suicides occurred in
these trials.
DESCRIPTION
LEXAPRO (escitalopram oxalate)
is an orally administered
selective Lexapro serotonin reuptake
inhibitor (SSRI). Escitalopram
is the pure S-enantiomer
(single isomer) of the racemic
bicyclic phthalane derivative
citalopram. Escitalopram
oxalate is designated S(+)-1-
[3-(dimethyl-amino)propyl]-1-
(p-fluorophenyl)- 5-
phthalancarbonitrile, Lexapro with the
following
scitalopram oxalate occurs as a
fine white Lexapro to slightly yellow
powder and is freely soluble
in methanol Lexapro and dimethyl
sulfoxide Lexapro (DMSO), soluble in
isotonic saline solution,
sparingly soluble Lexapro in water and
ethanol, slightly soluble in
ethyl acetate, Lexapro and insoluble
in heptane. Lexapro
LEXAPRO
(escitalopram oxalate)
is available as tablets or as
an oral solution. Lexapro
LEXAPRO tablets are film coated,
round tablets Lexapro containing
escitalopram oxalate in
strengths equivalent to 5 mg,
10 mg and 20 mg escitalopram
base. The 10 and 20 mg tablets
are scored. Lexapro The tablets also
contain the following inactive
ingredients: Lexapro talc,
croscarmellose sodium,
microcrystalline Lexapro
cellulose/
colloidal silicon dioxide,
and magnesium stearate. The
film coating contains
hypromellose, titanium dioxide,
and polyethylene glycol.
LEXAPRO oral solution contains
escitalopram oxalate equivalent
to 1 mg/mL Lexapro escitalopram base.
It also contains the following
inactive ingredients: sorbitol,
purified water, Lexapro citric acid,
sodium citrate, malic acid,
glycerin, Lexapro propylene glycol,
methylparaben, propylparaben, Lexapro
and natural peppermint flavor.
Lexapro
pizza online
buy-pizza
cheese-pizza
chewing gum
chewing-gum
bukaki
best-bukaki
bukaki-best